SAN JOSE, Calif., March 8, 2021 /PRNewswire/ -- Anixa
Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused
on the treatment and prevention of cancer and infectious diseases,
announced today that Anixa's Chief Executive Officer, Dr.
Amit Kumar, has been invited to
present at the Inaugural Emerging Growth Virtual Conference,
presented by M Vest LLC and Maxim Group LLC. The conference
will take place on March 17 and 18
from 9:00 am-5:00 pm ET featuring
roundtable discussions with C-suite executives moderated by Maxim
Research Analysts, fireside chats with live Q&A, and
presentations from hundreds of issuers both domestically and
internationally.
During this virtual conference, Anixa will present along with
other important voices in the biotech industry. Dr. Kumar
will provide an overview of Anixa's business and an update on the
Company's programs. To attend the conference, sign up to
become an M-Vest member here:
https://www.m-vest.com/events/2021-emerging-growth-virtual-conference.
About Anixa Biosciences, Inc.
Anixa is a
publicly-traded biotechnology company developing a number of
programs addressing cancer and infectious disease. Anixa's
therapeutics portfolio includes a cancer immunotherapy program
which uses a novel type of CAR-T, known as chimeric endocrine
receptor T-cell (CER-T) technology, and a Covid-19 therapeutics
program focused on inhibiting certain viral protein function.
The company's vaccine portfolio includes a vaccine to prevent
breast cancer, and specifically triple negative breast cancer
(TNBC), the most deadly form of the disease, and a vaccine to
prevent ovarian cancer. These vaccine technologies focus on
immunizing against specific proteins that have been found to be
expressed in certain forms of cancer. Anixa continually
examines emerging technologies in complementary fields for further
development and commercialization. Additional information is
available at www.anixa.com.
About M Vest LLC
M Vest LLC is an online
investment bank and digital community built for issuers, investors,
and thought leaders to share information and access investment
opportunities through capital raisings of Regulation D and
Regulation A Offerings. Founded in 2017 and headquartered in
New York City, M-Vest provides
insights on current equity market trends, hosts presentations from
public companies, and provides access to capital for emerging
growth companies. M-Vest hosts live conferences and webinars
featuring CEOs discussing the latest developments in their
industries. M Vest LLC is a registered broker-dealer with the U.S.
Securities and Exchange Commission (SEC), is a member of FINRA and
SIPC, and is a sister company of Maxim Group, LLC.
About Maxim Group LLC
Maxim Group LLC is a
full-service investment banking, securities and wealth management
firm headquartered in New York.
The Firm provides a full array of financial services
including investment banking; private wealth management; and global
institutional equity, fixed-income and derivatives sales &
trading, equity research and prime brokerage services. Maxim
Group is a registered broker-dealer with the U.S. Securities and
Exchange Commission (SEC) and the Municipal Securities Rulemaking
Board (MSRB). Member of FINRA SIPC, and NASDAQ. To
learn more about Maxim Group, visit maximgrp.com.
Investor contact:
Mike Catelani
mcatelani@anixa.com
408-708-9808
Media contact:
Sherry Ash
anixapress@gmail.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/anixa-biosciences-to-participate-in-m-vest-llc-and-maxim-group-llc-inaugural-emerging-growth-virtual-conference-301241879.html
SOURCE Anixa Biosciences, Inc.